메뉴 건너뛰기




Volumn 105, Issue 8, 2005, Pages 3003-

NK cell cytokine secretion regulated by SHIP1

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; MONOKINE; PHOSPHATASE; TUMOR NECROSIS FACTOR;

EID: 20144389283     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2005-02-0445     Document Type: Review
Times cited : (1)

References (5)
  • 1
    • 0035874522 scopus 로고    scopus 로고
    • Human natural killer cells: A unique innate immunoregulatory role for the CD56(bright) subset
    • Cooper MA, Fehniger TA, Turner SC, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001;97:3146-3151.
    • (2001) Blood , vol.97 , pp. 3146-3151
    • Cooper, M.A.1    Fehniger, T.A.2    Turner, S.C.3
  • 2
    • 0026512503 scopus 로고
    • Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation
    • Soiffer RJ, Murray C, Cochran K, et al. Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation. Blood. 1992;79:517-526.
    • (1992) Blood , vol.79 , pp. 517-526
    • Soiffer, R.J.1    Murray, C.2    Cochran, K.3
  • 3
    • 0027531423 scopus 로고
    • Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2
    • Caligiuri MA, Murray C, Robertson MJ, et al. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J Clin Invest. 1993;91:123-132.
    • (1993) J Clin Invest , vol.91 , pp. 123-132
    • Caligiuri, M.A.1    Murray, C.2    Robertson, M.J.3
  • 4
    • 0029811148 scopus 로고    scopus 로고
    • Rational interleukin 2 therapy for HIV positive individuals: Daily low doses enhance immune function without toxicity
    • Jacobson EL, Pilaro F, Smith KA. Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity. Proc Natl Acad Sci U S A. 1996;93:10405-10410.
    • (1996) Proc Natl Acad Sci U S A , vol.93 , pp. 10405-10410
    • Jacobson, E.L.1    Pilaro, F.2    Smith, K.A.3
  • 5
    • 0037606040 scopus 로고    scopus 로고
    • CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: A potential new link between adaptive and innate immunity
    • Fehniger TA, Cooper MA, Nuovo GJ, et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood. 2003;101: 3052-3057.
    • (2003) Blood , vol.101 , pp. 3052-3057
    • Fehniger, T.A.1    Cooper, M.A.2    Nuovo, G.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.